Skip navigation

Navigate Global and Country-Specific Regulations and Reimbursement Models for Early and Expedited Access

May 16-17, 2018
  • Amsterdam, The Netherlands

CBI’s 3rd Annual Managed Access Programmes and Accelerated Pathways is dedicated to the nuances and complexities of designing and implementing early access programs. Focused on global considerations for a variety of access management programs, including, but not limited to: Expanded Access Programs, Early Access Programs, Compassionate Use Programs, Named Patient Programs and Managed Access Programs.

A broad array of key stakeholders are coming together for an in-depth and meaningful discussion on Managed Access Programs where the implications, prevailing policies and current industry approaches are discussed in detail. Don’t miss the opportunity to join your peers and share best practices around providing investigational, pre-launch or end-of-lifecycle drugs to patients for treatment purposes.

2018 Features graphic
PLUS! Tour the Complex Regulatory Landscape During our World Showcase:

Navigate Country-Specific Regulations for Extending Treatment Globally

Managed Access Programmes and Accelerated Pathways

Navigate Global and Country-Specific Regulations and Reimbursement Models for Early and Expedited Access

CBI’s 3rd Annual Managed Access Programmes and Accelerated Pathways is dedicated to the nuances and complexities of designing and implementing early access programs. Focused on global considerations for a variety of access management programs, including, but not limited to: Expanded Access Programs, Early Access Programs, Compassionate Use Programs, Named Patient Programs and Managed Access Programs.

A broad array of key stakeholders are coming together for an in-depth and meaningful discussion on Managed Access Programs where the implications, prevailing policies and current industry approaches are discussed in detail. Don’t miss the opportunity to join your peers and share best practices around providing investigational, pre-launch or end-of-lifecycle drugs to patients for treatment purposes.

2018 Features graphic
PLUS! Tour the Complex Regulatory Landscape During our World Showcase:

Navigate Country-Specific Regulations for Extending Treatment Globally